• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

BerGenBio

Selective AXL inhibitors

  • About BerGenBio
    • About BerGenBio
    • Management Team
    • Board of Directors
    • Partners
  • Pipeline
    • Pipeline overview
    • bemcentinib | NSCLC
    • bemcentinib | COVID-19
    • bemcentinib | Melanoma
    • bemcentinib | AML
    • BGB149
    • BGB601
    • Discovery
    • Publications
    • Expanded access policy
  • Media Centre
    • News
    • Events
    • COVID-19 Media Pack
    • Media Contacts
  • Investors
    • Share Information
    • Largest Shareholders
    • Stock Exchange Notices
    • Presentations
    • Financial Reports
    • Financial Calendar
    • Analysts
    • General Meetings
    • Corporate Governance
    • IR Contacts
  • Careers
  • Contact
Home  /  Investors  /  Analyst Coverage

Analyst Coverage

The equity/research analysts listed below currently write research reports on BerGenBio ASA

Carnegie
Ulrik Trattner
Telephone: +46 8 5886 8589
E-mail: ulrik.trattner@carnegie.se

DNB
Patrik Ling
Telephone: +46 8 473 48 43
E-mail: patrik.ling@dnb.se

H.C. Wainwright & Co
Joseph Pantginis
Telephone: +1 646 975 6968
E-mail: jpantginis@hcwresearch.com

Jones Trading
Soumit Roy
Telephone: +1 646 454 2714
E-mail: sroy@jonestrading.com

Arctic Securities
Lars Mørland Knudsen
Telephone:+47 229 37 280
E-mail: lars.knudsen@arctic.com

Sponsored analyst coverage: 

Edison Group
Dr. Susie Jana
Telephone:+44 20 3077 5700
E-mail: sjana@edisongroup.com

Link to report:
https://www.edisongroup.com/company/bergenbio/2949/

Please note that any opinions, estimates or forecasts regarding BerGenBio ASA’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of BerGenBio ASA or its management. BerGenBio ASA does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Primary Sidebar

  • Investors
    • Share Information
    • Largest Shareholders
    • Stock Exchange Notices
    • Presentations
    • Financial Reports
    • Financial Calendar
    • Analysts
    • General Meetings
    • Corporate Governance
    • IR Contacts

News Subscription

Please remember to confirm your email by clicking on the link provided in the subscription confirmation email.

We will save your name and email address with the sole purpose of sending information regarding our latest news and events. By subscribing to BerGenBio’s newsletter you consent to our Privacy Policy and Terms of Use.

Footer

Key Information

  • Pipeline
  • Investors
  • News
  • Presentations
  • Management Team

Useful Information

  • Privacy Policy
  • Terms of Use
  • Job Applicant Privacy Notice
  • Site Map

Get In Touch

BerGenBio ASA
Company registration number 992 219 688

Jonas Lies vei 91, 5009 Bergen, Norway

www.bergenbio.com

+ 47 559 61 159

Copyright © 2017 BerGenBio ASA. All right reserved. Designed by Utopian Designs